Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
37 hedge funds and large institutions have $59.7M invested in Apollo Endosurgery, Inc. in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 0 closing their positions.
333% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 3
67% more capital invested
Capital invested by funds: $35.8M → $59.7M (+$23.9M)
37% more funds holding
Funds holding: 27 → 37 (+10)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.04M |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$2.64M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$2.49M |
| 4 |
GS
Gagnon Securities
New York
|
+$2.25M |
| 5 |
GA
Gagnon Advisors
New York
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
-$317K |
| 2 |
NSEDCP
NJ State Employees Deferred Compensation Plan
Trenton,
New Jersey
|
-$12.4K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$10.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $80K | +$50.7K | +8,157 | +249% |
|
27
UBS Group
Zurich,
Switzerland
| $26K | +$12.3K | +1,982 | +118% |
|
|
RWA
28
Ropes Wealth Advisors
Boston,
Massachusetts
| $13K | – | – | – |
|
|
TDC
29
Thompson Davis & Co
Richmond,
Virginia
| $12K | +$7.77K | +1,250 | +250% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $9K | +$6.84K | +1,100 | +1,068% |
|
31
Bank of America
Charlotte,
North Carolina
| $3K | +$1.3K | +209 | +113% |
|
|
VFA
32
Valeo Financial Advisors
Carmel,
Indiana
| $1K | +$1.19K | +192 | New |
|
|
RE
33
RBC Europe
London,
United Kingdom
| $7 | – | – | – |
|
APEN Hedge Fund Activity: Q2 2018 in Review
37 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2018, worth a combined $59.7M — up 67% from $35.8M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new APEN positions and 0 closed out — a net gain of 10 holders — while 13 added to existing stakes and 3 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $4.04M. The largest seller was University of Texas/Texas AM Investment Management Co (UTIMCO), cutting an estimated $317K.
- 37 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2018, up from 27 in Q1 2018.
- Funds reported $59.7M of Apollo Endosurgery, Inc. stock for Q2 2018, up 67% quarter-over-quarter.
- 10 funds opened new Apollo Endosurgery, Inc. positions in Q2 2018 and 0 closed out, a net change of +10 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q2 2018 was Nantahala Capital Management, an estimated $4.04M added.
- The largest Apollo Endosurgery, Inc. seller in Q2 2018 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $317K sold.
Based on aggregated 13F filings for Q2 2018.